FACTORS ASSOCIATED WITH INITIATION OF PRIMARY MEDICAL-CARE FOR HIV-INFECTED PERSONS

被引:36
作者
SAMET, JH
RETONDO, MJ
FREEDBERG, KA
STEIN, MD
HEEREN, T
LIBMAN, H
机构
[1] BOSTON UNIV,BOSTON CITY HOSP,SCH MED,DEPT MED,CLIN AIDS PROGRAM,BOSTON,MA 02118
[2] OREGON HLTH SCI UNIV,HOSP GOOD SAMARITAN,DEPT MED,PORTLAND,OR
[3] BROWN UNIV,SCH MED,DEPT MED,PROVIDENCE,RI 02912
[4] BOSTON UNIV,SCH PUBL HLTH,DEPT BIOSTAT & EPIDEMIOL,BOSTON,MA
关键词
D O I
10.1016/0002-9343(94)90301-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE: To examine the degree of immune dysfunction of human immunodeficiency virus (HIV)-infected patients at the time of presentation and to identify factors associated with early and late initial primary medical care for HIV infection as measured by CD4+ lymphocyte count. PATIENTS AND METHODS: Two hundred fifty-one consecutive outpatients without prior primary care for HIV infection were assessed at a municipal hospital HIV intake clinic (derivation group). Sociodemographic and clinical variables were examined for their association with CD4+ cell count on presentation in bivariate and stepwise linear regression analyses. Variables of interest were examined in 123 similar patients at a second site to assess the generalizability of our findings (validation group). RESULTS: In the derivation group, 30% of patients presented for initial primary care with CD4+ cell counts less than 200/mm(3), 51% had counts from 201/mm(3) to 500/mm(3), and only 19% had counts greater than 500/mm(3). Twenty-seven percent of patients had delayed seeking medical care for longer than 1 year and 12%, for more than 2 years after an initial positive HIV serologic evaluation. Three variables were significant and independent predictors of CD4+ cell count on presentation: Haitian ethnicity (P = 0.05) and HIV-related symptoms (P = 0.005) were associated with lower CD4+ cell counts; and female sex (P = 0.009) was associated with higher CD4+ cell counts. With HIV-related symptoms excluded from the model, a history of cocaine use was also a significant predictor for higher CD4+ cell count (P = 0.02). In the validation group, which included few Haitians, results for female sex and HIV-related symptoms showed a similar association. CONCLUSIONS: Most HIV-infected patients presented for primary care with advanced immune dysfunction. A substantial percentage of patients waited over a year to initiate medical care after testing positive for HIV. Haitian patients presented later for primary HIV care as measured by CD4+ cell count. Women presented with significantly higher CD4+ cell counts than did men. Since few characteristics examined could clearly identify the majority of late-presenting HIV-infected patients, improved general and targeted efforts are needed to link all HIV-infected people with primary medical care before the development of advanced disease.
引用
收藏
页码:347 / 353
页数:7
相关论文
共 35 条
[1]   PRELIMINARY-ANALYSIS OF THE CONCORDE TRIAL [J].
ABOULKER, JP ;
SWART, AM .
LANCET, 1993, 341 (8849) :889-890
[2]   EFFECTS OF DISEASE STAGE AND ZIDOVUDINE THERAPY ON THE DETECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN SEMEN [J].
ANDERSON, DJ ;
OBRIEN, TR ;
POLITCH, JA ;
MARTINEZ, A ;
SEAGE, GR ;
PADIAN, N ;
HORSBURGH, CR ;
MAYER, KH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (20) :2769-2774
[3]   INCUBATION PERIOD OF AIDS IN SAN-FRANCISCO [J].
BACCHETTI, P ;
MOSS, AR .
NATURE, 1989, 338 (6212) :251-253
[4]  
COHEN J B, 1991, Journal of Addictive Diseases, V10, P99, DOI 10.1300/J069v10n04_08
[5]   THE RISK OF DETERMINING RISK WITH MULTIVARIABLE MODELS [J].
CONCATO, J ;
FEINSTEIN, AR ;
HOLFORD, TR .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (03) :201-210
[6]   THE PROGNOSTIC VALUE OF CELLULAR AND SEROLOGIC MARKERS IN INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 [J].
FAHEY, JL ;
TAYLOR, JMG ;
DETELS, R ;
HOFMANN, B ;
MELMED, R ;
NISHANIAN, P ;
GIORGI, JV .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (03) :166-172
[7]   THE SAFETY AND EFFICACY OF ZIDOVUDINE (AZT) IN THE TREATMENT OF SUBJECTS WITH MILDLY SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV) INFECTION - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
FISCHL, MA ;
RICHMAN, DD ;
HANSEN, N ;
COLLIER, AC ;
CAREY, JT ;
PARA, MF ;
HARDY, WD ;
DOLIN, R ;
POWDERLY, WG ;
ALLAN, JD ;
WONG, B ;
MERIGAN, TC ;
MCAULIFFE, VJ ;
HYSLOP, NE ;
RHAME, FS ;
BALFOUR, HH ;
SPECTOR, SA ;
VOLBERDING, P ;
PETTINELLI, C ;
ANDERSON, J .
ANNALS OF INTERNAL MEDICINE, 1990, 112 (10) :727-737
[8]  
FREEDBERG KA, IN PRESS J ACQUIR IM
[9]   EPIDEMIOLOGY OF LATE PRESENTATION OF HIV-INFECTION IN WESTERN AUSTRALIA [J].
GILLIEATT, SJ ;
MALLAL, SA ;
FRENCH, MAH ;
DAWKINS, RL .
MEDICAL JOURNAL OF AUSTRALIA, 1992, 157 (02) :117-118
[10]   CD4 LYMPHOCYTE COUNTS WITHIN 24 MONTHS OF HUMAN-IMMUNODEFICIENCY-VIRUS SEROCONVERSION - FINDINGS IN THE UNITED-STATES-NAVY AND MARINE-CORPS [J].
GORHAM, ED ;
GARLAND, FC ;
MAYERS, DL ;
GOFORTH, RR ;
BRODINE, SK ;
WEISS, PJ ;
MCNALLY, MS .
ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (07) :869-876